AFIB - Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17 revenue of $4.1M beats by $0.13M
- Acutus Medical press release ( NASDAQ: AFIB ): Q2 Non-GAAP EPS of -$0.93 misses by $0.17 .
- Revenue of $4.1M (-13.0% Y/Y) beats by $0.13M .
- “Our teams continued to execute our strategy in the second quarter, as we intensify focus on utilization and procedure volume as the key drivers of our business,” said David Roman, President & CEO of Acutus. “We registered another quarter of record procedure volumes with year-over-year growth worldwide. Higher procedure volume was complemented by increased revenue share capture within our accounts, as electrophysiologists increase adoption of the Acutus product portfolio. In addition to positive trends in utilization, we made significant strides to strengthen our financial position, completing the first closing of our left-heart access portfolio sale to Medtronic, refinancing our debt, and implementing further cost reduction initiatives.”
For further details see:
Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M